Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2020

May 1, 2020

30786_dirs_2020-05-01_83d199d1-90b8-4222-aac3-35eb4c660303.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2020-04-29

Reporting Person: RAMALINGAM AJIT (EVP, Chief Accounting Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-04-29 Restricted Stock Units $0 A 1384 Acquired Bio-Rad A Common Stock (1384) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F2: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.